About Tg Therapeutics (TGTX)
TG Therapeutics, Inc. is a commercial-stage biopharmaceutical company that is focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The Company’s two programs in Phase III ... Read more
- USD16.75
- USD17.00
- USD15.96
- USD35.32
- 13.70%
- 289M
- 4.80M
- 4.07M
- 2.1B
- 6.46
- -47.30%
Stock News
20 minutes ago
Here's how much money you'd have lost if you invested $1,000 in Peloton when it went public
CNBC
26 minutes ago
SiriusXM to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
Yahoo
26 minutes ago
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo
31 minutes ago
Skittles is giving away a 1-year stay in an NYC micro-apartment that usually rents for $3,500/month: Take a look inside
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
